T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
SLM Corp
SLM
$5.22B
| $170M | 0.03% |
23,595,638
-43,607
| -0.2% | -$421K |
|
452
Tesla
TSLA
$1.34T
| $170M | 0.03% |
4,855,530
-20,878,515
| -81% | -$866M |
|
|
MYOK
453
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $168M | 0.03% |
3,588,514
+9,806
| +0.3% | +$628K |
|
454
Camden Property Trust
CPT
$11.1B
| $168M | 0.03% |
2,118,316
+214,617
| +11% | +$22.3M |
|
455
CarMax
KMX
$8.52B
| $166M | 0.03% |
3,091,363
-279,305
| -8% | -$23.6M |
|
456
Darden Restaurants
DRI
$25.4B
| $165M | 0.03% |
3,036,096
+807,850
| +36% | +$78.6M |
|
457
Sarepta Therapeutics
SRPT
$1.95B
| $165M | 0.03% |
1,686,799
-1,635,105
| -49% | -$187M |
|
|
HES
458
DELISTED
Hess
HES
| $163M | 0.03% |
4,896,798
-1,451,445
| -23% | -$78.5M |
|
459
Westlake Corp
WLK
$10.2B
| $163M | 0.03% |
4,264,295
+854,686
| +25% | +$48M |
|
460
Dow Inc
DOW
$21.9B
| $163M | 0.03% |
5,566,196
-3,442,550
| -38% | -$146M |
|
461
SLB Ltd
SLB
$77.3B
| $163M | 0.03% |
12,048,158
-5,789,251
| -32% | -$168M |
|
462
Freeport-McMoran
FCX
$93.6B
| $162M | 0.03% |
24,044,274
-30,669,130
| -56% | -$321M |
|
463
Southwest Airlines
LUV
$22B
| $162M | 0.03% |
4,542,054
-2,400,868
| -35% | -$119M |
|
|
MNTA
464
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $161M | 0.03% |
5,922,745
+51,560
| +0.9% | +$1.44M |
|
465
Allegion
ALLE
$14.2B
| $159M | 0.03% |
1,730,616
-50,570
| -3% | -$6.05M |
|
466
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $159M | 0.03% |
616,385
+611,801
| +13,346% | +$187M |
|
467
Bankunited
BKU
$3.41B
| $159M | 0.03% |
8,477,932
+1,122,170
| +15% | +$33.5M |
|
|
ZNGA
468
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $158M | 0.03% |
23,120,008
+3,265,111
| +16% | +$21.5M |
|
469
Rexford Industrial Realty
REXR
$8.12B
| $158M | 0.03% |
3,855,013
+121,747
| +3% | +$5.6M |
|
470
Essex Property Trust
ESS
$18.5B
| $158M | 0.03% |
716,826
-88,399
| -11% | -$25.4M |
|
471
Capitol Federal Financial
CFFN
$1.09B
| $157M | 0.02% |
13,552,591
+505,320
| +4% | +$6.47M |
|
|
CSFL
472
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $157M | 0.02% |
9,092,259
+119,687
| +1% | +$2.59M |
|
473
Nomad Foods
NOMD
$1.68B
| $156M | 0.02% |
8,409,203
-6,426,558
| -43% | -$125M |
|
474
Dominion Energy
D
$60.3B
| $156M | 0.02% |
2,156,424
+566,286
| +36% | +$46.2M |
|
475
Xencor
XNCR
$1.71B
| $154M | 0.02% |
5,162,357
-294,724
| -5% | -$9.76M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.